Colleen Tupper is CFO & VP at COLLEGIUM PHARMACEUTICAL, INC (COLL). They have made 2 open-market trades across 1 company since 2022, most recently 2026-02-10.
CIK 0001862082
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| COLL | 147,282 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2026-02-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| COLL | SELL · 10b5-1 | 2025-11-06 | 2025-11-07 | $40.53 | $2.4M | +5.0% | +13.1% | +10.8% |
| COLL | SELL · 10b5-1 | 2025-03-20 | 2025-03-24 | $30.03 | $420K | -4.7% | -14.7% | -1.9% |
| COLL | SELL · 10b5-1 | 2025-03-14 | 2025-03-18 | $30.00 | $29K | +0.0% | -9.1% | +0.0% |
| COLL | SELL · 10b5-1 | 2025-03-11 | 2025-03-13 | $30.01 | $627K | +3.9% | -7.9% | +2.3% |
| COLL | SELL · 10b5-1 | 2025-03-06 | 2025-03-10 | $30.00 | $104K | +1.1% | -10.9% | +2.9% |
| COLL | SELL · 10b5-1 | 2024-05-28 | 2024-05-29 | $34.21 | $1.3M | +0.8% | -2.5% | +14.4% |
| COLL | SELL | 2023-03-15 | 2023-03-17 | $23.77 | $1.5M | +0.4% | -3.1% | -7.4% |
| COLL | SELL | 2022-10-04 | 2022-10-06 | $17.35 | $151K | +4.7% | +18.2% | +59.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.